Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ananda PharmaAQSE:ANA +14.58% Market Cap is £2.37 Mil as of Jul. 22, 2026. The stock has 5 warning signs investors should review. Among 1,022 Drug Manufacturers companies, Ananda Pharma ranks worse than 94.03% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ananda Pharma's share price for the quarter that ended in Jul. 2025 was £0.0035. Ananda Pharma's Shares Outstanding (EOP) for the quarter that ended in Jul. 2025 was 4,299.15 Mil. Therefore, Ananda Pharma's market cap for the quarter that ended in Jul. 2025 was £15.05 Mil.
Ananda Pharma's quarterly market cap
declined
from Jul. 2024 (£20.22 Mil) to Jan. 2025 (£19.13 Mil) and
declined
from Jan. 2025 (£19.13 Mil) to Jul. 2025 (£15.05 Mil).
Ananda Pharma's annual market cap
increased
from Jan. 2023 (£5.38 Mil) to Jan. 2024 (£9.35 Mil) and
increased
from Jan. 2024 (£9.35 Mil) to Jan. 2025 (£19.13 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ananda Pharma's Enterprise Value for Today is £2.55 Mil.
Ananda Pharma (AQSE:ANA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ananda Pharma Market Cap Related Terms
Ananda Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for Ananda Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQSE:ANA vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ananda Pharma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Ananda Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ananda Pharma's Market Cap for the fiscal year that ended in Jan. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ananda Pharma (AQSE:ANA) has a Market Cap of £2.37 Mil as of Jul. 22, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ananda Pharma and its competitors. According to the industry distribution chart, Ananda Pharma ranks #961 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 94%.
Is Ananda Pharma's Market Cap too high?
Ananda Pharma's current Market Cap is £2.37 Mil. Based on the distribution chart, Ananda Pharma ranks #961 out of 1022 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Ananda Pharma's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ananda Pharma ranks #961 out of 1022 companies for Market Cap. This places Ananda Pharma in the lower half of its industry. The industry median Market Cap is 215.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 215.88, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ananda Pharma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 215.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ananda Pharma's current Market Cap is £2.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ananda Pharma stock overvalued right now?
Ananda Pharma (AQSE:ANA) has a current Market Cap of £2.37 Mil. The current Market Cap is £2.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ananda Pharma (AQSE:ANA), the current Market Cap is £2.37 Mil as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSE:ANA has been successfully added to your 
